Cancer drugs costly for many Canadians, free for others

 National pharmacare program offering universal prescription coverage for all Canadians could help decrease inequities for cancer patients Prescription drug coverage is a major problem in Canada. Canadians not only pay significantly more for medication than consumers in many other developed countries but many inequities in access exist. One’s age, profession,

Is Waiting Longer for New Prescription Drug Approvals Necessarily a Bad Thing?

 Why Canada’s ‘slow and low’ approach to new pharmaceuticals may be the prudent approach. The newest report from Canada’s brand name drug makers on access to new drugs has one key message: compared to other countries, Canada goes slow and low.  New drugs are slower to be covered by our